Literature DB >> 12919719

Susceptibility and exposure biomarkers in people exposed to PAHs from diesel exhaust.

M Adonis1, V Martínez, R Riquelme, P Ancic, G González, R Tapia, M Castro, D Lucas, F Berthou, L Gil.   

Abstract

Xenobiotic metabolizing enzymes, especially CYP1A1 and GSTM1, are involved in the activation and conjugation of PAHs and are controlled by polymorphic genes. PAHs released from diesel emissions in many cities of the world, especially in developing countries, contribute significantly to the toxic effects of airborne inhalable particles. We have evaluated the gene-environment interaction in Santiago of Chile, studying the contribution of CYP1A1 and GSTM1 polymorphisms on 1-OH-P urinary levels used as the PAHs exposure biomarker. The study was performed on 59 diesel exposed (38 diesel revision workers and 21 subjects working in an urban area as established street vendors) and 44 non-exposed subjects living in a rural area. The 1-OH-P urinary levels of the urban (P=0.043) and rural (P=0.040) populations showed, without considering the genotypes, significant differences between smokers and non-smokers, but no significant differences were found between smokers and non-smokers among the diesel plant workers (P=0.33). Non-smoking subjects of the diesel plants and the urban area showed similar 1-OHP levels (P=0.466) which were significantly higher than those of the subjects living in the rural area (P<0.05). When 1-OH-P levels were related with genotypes, an association was observed for the CYP1A1*2A genotype, so that the diesel-exposed workers carrying the CYP1A1*2A allele showed significantly higher 1-OH-P levels than the subjects from the rural area with the same genotype (P=0.008). On the other hand, there was no significant correlation between urinary 1-OH-P levels and GSTM1 null genotype, although higher levels of the urinary metabolite were found in individuals carrying the combined CYP1A1*2A and GSTM1 null genotype (P=0.055). These results may suggest an association between levels of the exposure biomarker 1-OH-P and presence of the CYP1A1*2A genotype, a potential genetic susceptibility biomarker which might be useful in identifying individuals at higher risk among people exposed to high PAH levels in diesel exhaust.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12919719     DOI: 10.1016/s0378-4274(03)00225-x

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  5 in total

1.  Increase of urinary concentrations of 8-hydroxy-2'-deoxyguanosine in diesel exhaust emission inspector exposed to polycyclic aromatic hydrocarbons.

Authors:  Mei-Wen Lee; Mei-Lien Chen; Shih-Chun Candice Lung; Chung-Jung Tsai; Chao-Feng Steven Lai; Shang-Chun Yang; I-Fang Mao
Journal:  Int Arch Occup Environ Health       Date:  2011-06-15       Impact factor: 3.015

2.  Are urinary PAHs biomarkers of controlled exposure to diesel exhaust?

Authors:  Sixin S Lu; Jon R Sobus; Gerd Sallsten; Maria Albin; Joachim D Pleil; Anders Gudmundsson; Michael C Madden; Bo Strandberg; Aneta Wierzbicka; Stephen M Rappaport
Journal:  Biomarkers       Date:  2014-04-22       Impact factor: 2.658

3.  Is urinary 1-hydroxypyrene a valid biomarker for exposure to air pollution in outdoor workers? A meta-analysis.

Authors:  Manuela Ciarrocca; Maria Valeria Rosati; Francesco Tomei; Assuntina Capozzella; Giorgia Andreozzi; Gianfranco Tomei; Alessandro Bacaloni; Teodorico Casale; Jean Claude Andrè; Mario Fioravanti; Maria Fernanda Cuartas; Tiziana Caciari
Journal:  J Expo Sci Environ Epidemiol       Date:  2013-01-09       Impact factor: 5.563

4.  Bladder cancer and occupational exposure to diesel and gasoline engine emissions among Canadian men.

Authors:  Lidija Latifovic; Paul J Villeneuve; Marie-Élise Parent; Kenneth C Johnson; Linda Kachuri; Shelley A Harris
Journal:  Cancer Med       Date:  2015-10-28       Impact factor: 4.452

5.  High human exposure to pyrene (polycyclic aromatic hydrocarbon) in Kinshasa, a capital of the Democratic Republic of Congo.

Authors:  Joel Tuakuila; Martin Kabamba; Honoré Mata
Journal:  Arch Public Health       Date:  2013-06-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.